Diagnosing and preventing iron overload.

Area of Science:

• Nephrology
• Hematology
• Diagnostic Imaging

Background:

• Iron deficiency is common in hemodialysis patients, treated with parenteral iron.
• Iron therapy aims to restore hemoglobin but carries risks of iron overload and toxicity.
• Current guidelines use serum ferritin and transferrin saturation, which may be unreliable indicators of body iron stores.

Purpose of the Study:

• To evaluate the limitations of current iron monitoring markers in hemodialysis patients.
• To explore the potential role of magnetic resonance imaging (MRI) in assessing iron overload.
• To challenge the current clinical practice guidelines for iron therapy management.

Main Methods:

• Review of recent clinical trials and studies involving iron therapy in dialysis patients.
• Analysis of studies using magnetic resonance imaging (MRI) to quantify liver iron content (LIC).
• Comparison of MRI-derived LIC with liver biopsy and discussion of its correlation with total body iron.

Main Results:

• High-dose intravenous iron therapy in dialysis patients has been linked to increased cardiovascular morbidity and mortality.
• MRI studies indicate excessive liver iron content (LIC) in some dialysis patients, suggesting iron overload.
• LIC measured by MRI correlates with liver biopsy but its direct clinical relevance to mortality/morbidity needs further demonstration.

Conclusions:

• Current serum iron markers may not accurately guide safe iron therapy in hemodialysis patients.
• MRI shows promise for detecting iron overload, particularly in patients with high cumulative iron doses or long dialysis vintage.
• Further research is required to establish MRI's role in altering clinical management for iron overload in dialysis patients.